Saskatchewan judge to hear injunction application over school pronoun policy
Published Tue, 04 Mar 2025 07:31:56 GMT
Statistics Canada to release inflation figures for August this morning
Published Tue, 04 Mar 2025 07:31:56 GMT
Daily horoscope for September 19, 2023
Published Tue, 04 Mar 2025 07:31:56 GMT
Citizens and organizations invited to express their views on Erasmus+ and shape the future of the programme
Published Tue, 04 Mar 2025 07:31:56 GMT
Harriette Cole: A random man was staring in my window, and the police let him go
Published Tue, 04 Mar 2025 07:31:56 GMT
Miss Manners: We’d go to the wedding but we’re obviously on the bride’s B-list
Published Tue, 04 Mar 2025 07:31:56 GMT
Dear Abby: He never wants to see me again, but we may be thrown together
Published Tue, 04 Mar 2025 07:31:56 GMT
Tips for selling a house at the highest price — and fast
Published Tue, 04 Mar 2025 07:31:56 GMT
El “efecto Mandela” describe los recuerdos falsos que muchos de nosotros compartimos. Pero ¿por qué los científicos no pueden explicarlo?
Published Tue, 04 Mar 2025 07:31:56 GMT
A Chinese #MeToo journalist and an activist spent 2 years in detention. Their trial starts this week
Published Tue, 04 Mar 2025 07:31:56 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says